7 0 1 0 1 B-lower_bound
- 1 2 1 2 O
80 2 4 2 4 B-upper_bound
years 5 10 5 10 I-upper_bound
of 11 13 11 13 O
age 14 17 14 17 B-age

Acceptable 0 10 18 28 O
forms 11 16 29 34 O
of 17 19 35 37 O
birth 20 25 38 43 O
control 26 33 44 51 O
for 34 37 52 55 O
female 38 44 56 62 B-gender
patients 45 53 63 71 I-gender
include 54 61 72 79 O
: 61 62 79 80 O
hormonal 63 71 81 89 B-contraception_consent
birth 72 77 90 95 I-contraception_consent
control 78 85 96 103 I-contraception_consent
, 85 86 103 104 O
intrauterine 87 99 105 117 B-contraception_consent
device 100 106 118 124 I-contraception_consent
, 106 107 124 125 O
diaphragm 108 117 126 135 B-contraception_consent
with 118 122 136 140 I-contraception_consent
spermicide 123 133 141 151 I-contraception_consent
, 133 134 151 152 O
condom 135 141 153 159 B-contraception_consent
with 142 146 160 164 I-contraception_consent
spermicide 147 157 165 175 I-contraception_consent
, 157 158 175 176 O
or 159 161 177 179 O
abstinence 162 172 180 190 O
, 172 173 190 191 O
for 174 177 192 195 O
the 178 181 196 199 O
length 182 188 200 206 O
of 189 191 207 209 O
the 192 195 210 213 O
study 196 201 214 219 O

Cardiac 0 7 220 227 O
: 7 8 227 228 O
Cardiac 9 16 229 236 B-clinical_variable
ejection 17 25 237 245 I-clinical_variable
fraction 26 34 246 254 I-clinical_variable
> 35 36 255 256 O
/= 36 38 256 258 O
50 39 41 259 261 B-lower_bound
% 41 42 261 262 I-lower_bound
, 42 43 262 263 O
no 44 46 264 266 O
evidence 47 55 267 275 O
of 56 58 276 278 O
pericardial 59 70 279 290 B-chronic_disease
effusion 71 79 291 299 I-chronic_disease
as 80 82 300 302 O
determined 83 93 303 313 O
by 94 96 314 316 O
an 97 99 317 319 O
ECHO 100 104 320 324 B-treatment
or 105 107 325 327 O
MUGA 108 112 328 332 B-treatment
, 112 113 332 333 O
and 114 117 334 337 O
no 118 120 338 340 O
clinically 121 131 341 351 O
significant 132 143 352 363 O
ECG 144 147 364 367 O
findings 148 156 368 376 O

Hepatic 0 7 377 384 O
: 7 8 384 385 O
ALT 9 12 386 389 B-clinical_variable
/ 12 13 389 390 O
AST 13 16 390 393 B-clinical_variable
< 17 18 394 395 O
/= 18 20 395 397 O
2.5 21 24 398 401 B-upper_bound
x 25 26 402 403 I-upper_bound
ULN 27 30 404 407 I-upper_bound
or 31 33 408 410 O
< 34 35 411 412 O
/= 35 37 412 414 O
5 38 39 415 416 O
x 40 41 417 418 O
ULN 42 45 419 422 O
if 46 48 423 425 O
documented 49 59 426 436 O
liver 60 65 437 442 B-cancer
metastases 66 76 443 453 I-cancer
, 76 77 453 454 O
Total 78 83 455 460 O
bilirubin 84 93 461 470 B-clinical_variable
< 94 95 471 472 O
/= 95 97 472 474 O
1.5 98 101 475 478 B-upper_bound
mg 102 104 479 481 I-upper_bound
/ 104 105 481 482 I-upper_bound
dL 105 107 482 484 I-upper_bound
, 107 108 484 485 O
except 109 115 486 492 O
in 116 118 493 495 O
subjects 119 127 496 504 O
with 128 132 505 509 O
Gilbert 133 140 510 517 B-chronic_disease
's 140 142 517 519 I-chronic_disease
Syndrome 143 151 520 528 I-chronic_disease
in 152 154 529 531 O
whom 155 159 532 536 O
total 160 165 537 542 O
bilirubin 166 175 543 552 O
must 176 180 553 557 O
be 181 183 558 560 O
< 184 185 561 562 O
/= 185 187 562 564 O
3.0 188 191 565 568 B-upper_bound
mg 192 194 569 571 I-upper_bound
/ 194 195 571 572 I-upper_bound
dL 195 197 572 574 I-upper_bound

Known 0 5 575 580 O
positive 6 14 581 589 O
serology 15 23 590 598 O
for 24 27 599 602 O
HIV 28 31 603 606 B-chronic_disease

Patients 0 8 607 615 O
at 9 11 616 618 O
least 12 17 619 624 O
3 18 19 625 626 B-lower_bound
weeks 20 25 627 632 I-lower_bound
from 26 30 633 637 O
last 31 35 638 642 O
cytotoxic 36 45 643 652 B-treatment
chemotherapy 46 58 653 665 I-treatment
at 59 61 666 668 O
the 62 65 669 672 O
time 66 70 673 677 O
of 71 73 678 680 O
starting 74 82 681 689 O
lymphodepleting 83 98 690 705 B-treatment
chemotherapy 99 111 706 718 I-treatment

Patients 0 8 719 727 O
may 9 12 728 731 O
continue 13 21 732 740 O
tyrosine 22 30 741 749 B-treatment
kinase 31 37 750 756 I-treatment
inhibitors 38 48 757 767 I-treatment
or 49 51 768 770 O
other 52 57 771 776 O
targeted 58 66 777 785 B-treatment
therapies 67 76 786 795 I-treatment
until 77 82 796 801 O
at 83 85 802 804 O
least 86 91 805 810 O
two 92 95 811 814 B-lower_bound
weeks 96 101 815 820 I-lower_bound
prior 102 107 821 826 I-lower_bound
to 108 110 827 829 O
administration 111 125 830 844 O
of 126 128 845 847 O
lymphodepleting 129 144 848 863 B-treatment
chemotherapy 145 157 864 876 I-treatment

Patients 0 8 877 885 O
with 9 13 886 890 O
ALL 14 17 891 894 B-chronic_disease
, 17 18 894 895 O
CLL 19 22 896 899 B-chronic_disease
, 22 23 899 900 O
NHL 24 27 901 904 B-chronic_disease
with 28 32 905 909 O
relapsed 33 41 910 918 O
disease 42 49 919 926 O
following 50 59 927 936 O
standard 60 68 937 945 B-treatment
therapy 69 76 946 953 I-treatment
or 77 79 954 956 O
a 80 81 957 958 O
stem 82 86 959 963 B-treatment
cell 87 91 964 968 I-treatment
transplant 92 102 969 979 I-treatment

Patients 0 8 980 988 O
with 9 13 989 993 O
history 14 21 994 1001 O
of 22 24 1002 1004 O
CD 25 27 1005 1007 O
19 28 30 1008 1010 O
positive 31 39 1011 1019 O
B 40 41 1020 1021 B-cancer
- 41 42 1021 1022 I-cancer
lymphoid 42 50 1022 1030 I-cancer
malignancies 51 63 1031 1043 I-cancer
( 64 65 1044 1045 O
ALL 65 68 1045 1048 B-cancer
, 68 69 1048 1049 O
CLL 70 73 1050 1053 B-cancer
, 73 74 1053 1054 O
NHL 75 78 1055 1058 B-cancer
) 78 79 1058 1059 O
who 80 83 1060 1063 O
have 84 88 1064 1068 O
received 89 97 1069 1077 O
at 98 100 1078 1080 O
least 101 106 1081 1086 O
2 107 108 1087 1088 B-lower_bound
lines 109 114 1089 1094 O
of 115 117 1095 1097 O
standard 118 126 1098 1106 O
chemoimmunotherapy 127 145 1107 1125 B-treatment
or 146 148 1126 1128 O
targeted 149 157 1129 1137 B-treatment
therapy 158 165 1138 1145 I-treatment
and 166 169 1146 1149 O
have 170 174 1150 1154 O
persistent 175 185 1155 1165 O
disease 186 193 1166 1173 O

Presence 0 8 1174 1182 O
of 9 11 1183 1185 O
active 12 18 1186 1192 B-chronic_disease
neurological 19 31 1193 1205 I-chronic_disease
disorder(s 32 42 1206 1216 I-chronic_disease
) 42 43 1216 1217 I-chronic_disease

Presence 0 8 1218 1226 O
of 9 11 1227 1229 O
fungal 12 18 1230 1236 B-chronic_disease
, 18 19 1236 1237 O
bacterial 20 29 1238 1247 B-chronic_disease
, 29 30 1247 1248 O
viral 31 36 1249 1254 B-chronic_disease
, 36 37 1254 1255 O
or 38 40 1256 1258 O
other 41 46 1259 1264 O
infection 47 56 1265 1274 B-chronic_disease
requiring 57 66 1275 1284 O
IV 67 69 1285 1287 B-treatment
antimicrobials 70 84 1288 1302 I-treatment
for 85 88 1303 1306 O
management 89 99 1307 1317 O

